| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |